SPY
753.41
+0.17%
QQQ
683.36
+0.33%
BTC/USD
77,015.10
+0.44%
DIA
519.72
+0.07%
GLD
362.59
+0.26%
TLT
81.59
−0.17%
Try
Free
US
Sign in
Register
My Account
Benzinga
Premium Services
Services
Markets & News
Markets
Stocks & Sectors
Stocks
Ratings & Research
Ratings
Trading
Trading
Screeners & Lists
Screeners
Learn
Learn
Premium Services
Markets & News
Breaking headlines, the trading day, and the calendars that move it.
Stocks & Sectors
Research any ticker, then drill into sectors, ratings, and options.
Ratings & Research
Wall Street calls, insider moves, and Benzinga's own stock rankings.
Trading
Options flow, trade calculators, and ideas for active traders.
Screeners & Lists
Filter the market your way, or start from a curated list.
Learn
Pick a broker, grow your savings, and protect what you've built.
Premium Services
Edge
Ratings, signals & screens
Pro
Real-time news & data terminal
Research
Trade alerts & newsletters
APIs
Market data licensing
All sections
Cameco Corp
CCJ
NYSE
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$73.38
-3.53
-4.59%
Last update: Nov 2, 7:23 PM
Get Report
Overview
News
Earnings Forecast
Price Targets
Financials
Sentiment
Ownership
Dividends
Compare
Options
Stock Report
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga
Edge
Benzinga
Research
Benzinga
Pro
Logout
PRO
Why Is It Moving?™:
Shares of oil and gas-related companies are trading lower as oil prices dec...
Earnings:
Q3 2026 Earnings were released on Fri Oct 30th, before the market open
Conference Call:
The most recent conference call started at 8:00 AM, 3 days ago
Click to view the webcast
Cameco Financials
Cameco (CCJ) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Cameco Affirms FY2026 Sales Guidance of $2.398B-$2.580B vs $2.440B Est
Cameco (NYSE:CCJ) affirms FY2026 sales outlook from $2.398 billion-$2.580 billion to $2.398 billion-$2.580 billion vs $2.440 billion estimate.
Benzinga Newsdesk
PRO
Cameco Q3 Adj EPS $0.00 and Sales $619.000M Miss $767.666M Estimate
Cameco (TSX:CCO) reported quarterly sales of $619.000 million which missed the analyst consensus estimate of $767.666 million by 19.37 percent. This is a 0.65 percent increase over sales of $615.000 million the same
Benzinga Newsdesk
ExxonMobil, AbbVie On Deck Friday As Energy, Drug Growth Face Test
ExxonMobil headlines Friday’s reports, with investors watching whether strong energy production can sustain a sharp earnings recovery. AbbVie, Chevron, AstraZeneca, BP, Sanofi, General Dynamics, Regeneron
Benzinga Insights
PRO
Cameco Raises FY2026 Sales Guidance from $2.245B-$2.417B to $2.398B-$2.580B vs $2.390B Est
Cameco (NYSE:CCJ) raises FY2026 sales outlook from $2.245 billion-$2.417 billion to $2.398 billion-$2.580 billion vs $2.390 billion estimate.
Benzinga Newsdesk
PRO
Cameco Lowers FY2026 Sales Guidance from $3.130B-$3.370B to $2.398B-$2.580B vs $3.440B Est
Cameco (TSX:CCO) lowers FY2026 sales outlook from $3.130 billion-$3.370 billion to $2.398 billion-$2.580 billion vs $3.440 billion estimate.
Benzinga Newsdesk
PRO
Cameco Q2 Adj. EPS $0.13 Misses $0.36 Estimate, Sales $588.000M Beat $534.360M Estimate
Cameco (NYSE:CCJ) reported quarterly earnings of $0.13 per share which missed the analyst consensus estimate of $0.36 by 63.89 percent. This is a 74.51 percent decrease over earnings of $0.51 per share from the same
Benzinga Newsdesk
